Medicinal Product Shortages - update - 10 July 2024

Notice type: Advisory

Date: 10/07/2024

This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.

Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

Resolved shortages

The following shortages have been resolved and supply has resumed to the Irish market:

Product

Active Ingredient(s)

Abstral 400 microgram sublingual tablets

PA2288/004/005

Kyowa Kirin Holdings B.V.

Fentanyl

Aripiprazole Accord 30mg Tablets

EU/1/15/1045/020

Accord Healthcare S.L.U.

Aripiprazole

Cefuroxime 750 mg powder for solution for injection/infusion

PA2059/006/001

Fresenius Kabi Deutschland GmbH

Cefuroxime

Memantine Accord 20mg Film Coated Tablets

EU/1/13/880/021

Accord Healthcare S.L.U

Memantine

Montelukast Paediatric 5mg Chewable Tablets

PA2315/110/002

Accord Healthcare Ireland Ltd

Montelukast

Mycophenolate Mofetil Accord 250mg capsules

PA2315/064/001

Accord Healthcare Ireland Ltd.

Mycophenolate

Ozempic 0.5mg solution for Injection in pre-filled pen

EU/1/17/1251/003

Novo Nordisk A/S

Semaglutide

Paricalcitol 5 micrograms/ml solution for injection

 

PA0281/163/001

Pinewood Laboratories Ltd

Paricalcitol

Pioglitazone Accord 45mg Tablets

EU/1/11/722/022

Accord Healthcare Ireland Ltd.

Pioglitazone

Quetiapine 25mg Film Coated Tablets

PA2315/117/001

Accord Healthcare Ireland Ltd

Quetiapine

Sumatriptan 50mg Film Coated Tablets

PA2315/070/001

Accord Healthcare Ireland Ltd

Sumatriptan

Naltrexone Hydrochloride 50mg Film-Coated Tablets

PA2315/111/001

Accord Healthcare Ireland Ltd.

Naltrexone

Telmisartan/Hydrochlorothiazide 80 mg/25 mg tablets

PA2315/107/003

Accord Healthcare Ireland Ltd

Telmisartan

Zestan 2.5mg Tablets

PA0126/112/001

Clonmel Healthcare Ltd

Lisinopril

Zestan 5mg Tablets

PA0126/112/002

Clonmel Healthcare Ltd

Lisinopril

Zestan 10mg Tablets

PA0126/112/003

Clonmel Healthcare Ltd

Lisinopril

Zestan 20mg Tablets

PA0126/112/004

Clonmel Healthcare Ltd

Lisinopril

Newly notified shortages

The HPRA has been notified of a shortage of the following products:

Product

Active Ingredient(s)

Actiq 200 micrograms compressed lozenge with integral oromucosal applicator

PA0749/195/001

Teva Pharma B.V.

Fentanyl

Calcium Resonium 99.934 % Powder for oral or rectal suspension

PA0540/141/001

Sanofi-Aventis Ireland Limited T/A SANOFI

Calcium polystyrene sulphonate

Clonfolic 0.4mg Tablets

PA0126/095/001

Clonmel Healthcare Ltd

Folic acid

Dexamethasone Phosphate 4mg/ml Solution for Injection

PA0822/201/001

Pfizer Healthcare Ireland

Dexamethasone

Genotropin 5.3mg powder and solvent for solution for injection, with preservative

PA0822/128/001

Pfizer Healthcare Ireland

Somatropin

Linezolid Teva 600mg film-coated tablets

PA0749/204/001

Teva Pharma B.V.

Linezolid

Molipaxin 150mg Film Coated Tablets

PA23229/011/003

Neuraxpharm Ireland Limited

Trazodone

Retrovir 10 mg/ml IV concentrate for solution for infusion

PA22575/001/003

ViiV Healthcare BV

Zidovudine

Telmisartan Rowa 40mg Tablets

PA0074/078/002

Rowa Pharmaceuticals Limited

Telmisartan

Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.



« Back